黑色素瘤相关抗原3抗体
Antigen MZ2 D; Antigen MZ2-D; Cancer/testis antigen 1.3; Cancer/testis antigen family 1 member 3; CT1.3; HIP8; HYPD; MAGA3_HUMAN; MAGE 3 antigen; MAGE-3 antigen; MAGE3; MAGEA3; MAGEA6; Me
腺苷酸环化酶1抗体
3'5' cyclic AMP synthetase; ADCY1; adenyl cyclase; Adenylate cyclase 1; adenylate cyclase type I; ATP pyrophosphate lyase; Brain adenylate cyclase 1; Ca(2+)/calmodulin activated adenylyl cyclase; EC 4
磷酸化丝氨酸/苏氨酸蛋白激酶MARK1抗体
MARK1 (phospho T215); MARK 1 (phospho T215); p-MARK1 (phospho T215);KIAA1477; MAP/microtubule affinity regulating kinase 1; MAP/microtubule affinity-regulating kinase 1; MARK 1; MARK; Mark1; MAR
颗粒细胞分化蛋白抗体
FLJ31098; FLJ99857; GCDP; Granule cell differentiation protein; MTPN; MTPN_HUMAN; Myotrophin; Protein V 1; Protein V-1; V 1; MTPN_HUMAN.
Anti-MYOZ2 Polyclonal Antibody
Anti-MYOZ2 Polyclonal Antibody应用 WB 稀释比例 WB 1:5000-8000. 交叉反应 Human
Anti-ERCC1 Monoclonal Antibody
Anti-ERCC1 Monoclonal Antibody 应用 WB 稀释比例 WB 1:1000.交叉反应 Human